Goldman Sachs: Well Positioned Amid Economic Uncertainty, but Targets Still Too Lofty
Although Goldman remains highly leveraged, it has restructured as a bank holding company, which grants access to government borrowing facilities, thus decreasing its short-term funding concerns. The ...
Insurance Startup Ethos Taps Goldman as It Explores Going Public
Ethos, an insurance technology startup, is exploring an initial public offering that could occur as soon as this year and has ...
BioNTech SE (BNTX) Gets a Buy from Goldman Sachs
Goldman Sachs analyst Chris Shibutani maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $136.00.
Danaher upgraded at Goldman Sachs citing an attractive entry point
Danaher (NYSE:DHR) traded higher in the premarket on Friday after Goldman Sachs upgraded the life sciences company to Buy ...